Monthly Cost Reality: Wegovy vs Mounjaro Breakdown
What Is Best Wegovy or Mounjaro for Monthly Budget Planning?
When evaluating what is best Wegovy or Mounjaro from a monthly cost perspective, the financial commitment varies significantly between these two prescription-only medicines. Wegovy follows a structured 16-week dose escalation with predictable monthly costs, while Mounjaro offers a different pricing framework that may suit different budgeting preferences. The key difference lies in how costs accumulate over time and the long-term maintenance investment required.
Understanding your monthly financial commitment becomes crucial for sustainable treatment success. Wegovy's transparent pricing structure allows for clear annual budgeting, with maintenance dose costs remaining consistent at £209.99 monthly once you reach the 2.4mg dose. This predictability helps patients plan their long-term weight management investment alongside the required reduced-calorie diet and increased physical activity components.
Wegovy Monthly Costs: Complete UK Pricing Breakdown
Wegovy's month-by-month cost structure provides complete transparency for your weight management budget planning. Month 1 starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 in month 2 (0.5mg), £99.99 in month 3 (1mg), and £139.99 in month 4 (1.7mg). From month 5 onwards, the maintenance 2.4mg dose costs £209.99 monthly, creating a predictable ongoing investment of approximately £2,519.88 annually.
Our bundle options can provide convenience advantages for planning ahead, such as the Intro Duo combining months 1-2 for £169.99, or the Ultimate Stability Trio providing three months of maintenance supply for £649.99. New customers benefit from the FIRST40 discount code, while returning customers maintain competitive pricing with DOSE25, ensuring long-term affordability throughout your treatment journey.
What Is Best Wegovy or Mounjaro: Clinical Evidence Comparison
In clinical trials, Wegovy demonstrated significant weight management results, with the STEP 1 trial showing participants achieved an average of ~clinically studied weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). The STEP trial programme consistently showed sustained results across diverse patient populations with various comorbidities.
Mounjaro's clinical evidence comes from the SURMOUNT trials, showing impressive results in its patient populations, though direct head-to-head comparisons aren't available due to different trial designs and endpoints. Both treatments require clinical assessment and ongoing medical supervision, making the choice highly individual based on your specific health profile and treatment goals.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to support appetite regulation. This mechanism works by slowing gastric emptying, promoting earlier satiety signals, and potentially reducing food cravings through effects on brain appetite centres. The once-weekly injection delivers consistent medication levels, supporting steady appetite management throughout each week. Unlike Mounjaro's dual GIP and GLP-1 approach, Wegovy focuses specifically on the GLP-1 pathway, providing targeted appetite control that has been extensively studied across multiple clinical trials. This focused mechanism may suit patients who respond well to GLP-1 receptor stimulation as part of their comprehensive weight management programme.
Streamlined Ordering Process for Both Treatments
Accessing either Wegovy or Mounjaro through EverydayMeds requires just a 3-minute online clinical assessment covering your medical history, current medications, and treatment goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring safe and appropriate prescribing for your individual circumstances. Once approved, your prescription-only medicine ships via next-day delivery using our cold-chain, temperature-controlled logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance and professional pharmaceutical standards throughout the process. Both treatments require ongoing prescriber oversight, with regular review appointments to monitor progress and adjust treatment as needed.
Storage and Practical Considerations
Wegovy offers practical storage advantages with its 6-week room temperature stability once removed from refrigeration, compared to Mounjaro's 21-day limit, making travel and daily life more convenient. Both medications require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature window provides greater flexibility for busy lifestyles. The FlexTouch pen system delivers precise doses with simple operation, while the mandatory dose escalation protocol helps minimise side effects during treatment initiation. Each pen contains multiple doses depending on the strength, with clear instructions provided for proper injection technique and rotation of injection sites. Proper storage and handling ensure optimal medication effectiveness throughout your treatment programme.
What Is Best Wegovy or Mounjaro for Long-term Cost Predictability?
Monthly cost predictability becomes crucial when planning your weight management investment over multiple years. Wegovy's fixed maintenance dose pricing at £209.99 monthly allows for accurate annual budgeting and financial planning throughout your treatment journey. This consistency helps avoid unexpected cost fluctuations that might disrupt treatment continuity.
Mounjaro's different pricing structure may offer advantages for certain budget preferences, though the long-term cost comparison depends on individual response patterns and maintenance requirements. Both treatments represent significant monthly investments, making it essential to discuss financial sustainability with your prescriber as part of your comprehensive treatment planning approach.
Making Your Treatment Decision with EverydayMeds Support
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your medical profile, lifestyle needs, and budget considerations. Our clinical team evaluates not just medical suitability but also practical factors like cost sustainability and treatment adherence potential. The choice between these prescription-only medicines involves weighing mechanism differences, dosing schedules, storage requirements, and long-term financial commitment against your individual health goals. Our ongoing support includes regular prescription reviews, side effect monitoring, and treatment optimisation to ensure you achieve the best possible outcomes. Starting your assessment today with either FIRST40 (new customers) or DOSE25 (returning customers) provides immediate access to competitive pricing and professional clinical guidance.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
